MetLife stock target raised to 112 US dollars by Mizuho
Published on 11/11/2026 at 14:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view shifts after strong quarter
- Mizuho kept its Outperform rating after MetLife's third-quarter results.
- The analyst cited broad business growth, favorable mortality and expense discipline.
- MetLife's diversified benefits platform remains central to the earnings outlook.
Mizuho raised its price target for MetLife stock from 109 to 112 US dollars on Monday, November 9, while keeping an Outperform rating. The move followed the insurer's third-quarter results and reflects a more constructive view of earnings growth despite a modest reduction in the 2026 operating outlook, according to Investing.com.
MetLife stock traded at 92.75 euros on Lang & Schwarz at 14:14 CET on Wednesday, November 11, 2026.
Mizuho sees durable earnings drivers
Mizuho cited favorable Group Life mortality, higher variable investment income and expansion across several businesses as supports for the latest quarter. Those gains offset weaker underwriting in Asia, pressure in Group Disability's long-term disability business and a negative encaje return in Latin America.
The analyst also pointed to the breadth of MetLife's Group Benefits operation, stronger new-business economics and expense discipline. New business economics produced a 19 percent internal rate of return with a five-year payback for a third consecutive year, while a 50 basis point PineBridge headwind remained a factor for expenses.
Forecast changes remain measured
Mizuho cut its fiscal 2026 operating earnings-per-share estimate by less than 1 percent to 10.30 US dollars. Its normalized earnings-per-share estimate stayed at 10.23 US dollars. For the following two years, the firm raised its 2027 estimate to 11.30 US dollars and retained its 2028 estimate at 12.40 US dollars.
The forecast pattern suggests that the analyst sees the latest quarter as supportive of MetLife's medium-term earnings trajectory, but not as a reason to materially reset the near-term view. The report also said the insurer's disclosed exposure to hyperscalers and data centers represented 1 percent of the general account, limiting the direct sensitivity of that theme within the portfolio.
What the update means for investors
The target increase gives investors a fresh reference point after the earnings release, while the maintained rating indicates that Mizuho's positive stance rests on operating execution rather than a single quarter alone. The main variables remain the durability of Group Benefits growth, underwriting performance across regions and the company's ability to contain expenses as it pursues its broader strategy.
MetLife Inc. key facts
- Company: MetLife Inc.
- ISIN: US59156R1086
- WKN: 934623
- NYSE ticker: MET
- Lang & Schwarz price: 92.75 euros on Wednesday, November 11, 2026, at 14:14 CET
The broader US equity backdrop is covered in the S&P 500 market theme.
